Needle-Free Breakthrough? Vensica’s ViXe Program M...
Category : Clinical Trial Update 1 May 2026There’s a quiet bottleneck in urology. Not innovation. Not demand. Access. And it often comes...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
AOTI’s TWO2 Therapy: Can Oxygen Heal Chronic Wound...
Category : Clinical Trial Update 1 May 2026Chronic wounds are a silent drain on healthcare systems. They linger. They relapse. And too often, t...
Phase 3 Miss—Or Strategic Pivot? Renibus’ RBT-1 Da...
Category : Clinical Trial Update 1 May 2026Most Phase 3 failures are blunt. This one isn’t. Renibus Therapeutics just reported results fr...
Energenesis to Spotlight Diabetic Foot Ulcer Drug...
Category : Clinical Trial Update 30 April 2026Clinical-stage biotech Energenesis Biomedical Co., Ltd. is taking its lead wound-care candidate to a...
Viking Pushes Ahead in Obesity Race: Phase 3 Momen...
Category : Clinical Trial Update 30 April 2026The obesity drug race is accelerating—and Viking Therapeutics, Inc. is making a clear move to...
Latest Newsletter Post
-
Phase 3 Miss—Or Strategic Pivot? Re..
1 May 2026
-
AOTI’s TWO2 Therapy: Can Oxygen Hea..
1 May 2026
-
Needle-Free Breakthrough? Vensica’s..
1 May 2026
-
Novo Nordisk’s Denecimig Delivers S..
30 April 2026
-
Viking Pushes Ahead in Obesity Race..
30 April 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com